| Literature DB >> 31685918 |
Martín Cancela1,2,3, Jéssica A Paes4,5, Hercules Moura6, John R Barr6, Arnaldo Zaha4,7,5,8, Henrique B Ferreira9,10,11,12.
Abstract
Cystic hydatid disease (CHD) is a worldwide neglected zoonotic disease caused by Echinococcus granulosus. The parasite is well adapted to its host by producing protective molecules that modulate host immune response. An unexplored issue associated with the parasite's persistence in its host is how the organism can survive the oxidative stress resulting from parasite endogenous metabolism and host defenses. Here, we used hydrogen peroxide (H2O2) to induce oxidative stress in E. granulosus protoescoleces (PSCs) to identify molecular pathways and antioxidant responses during H2O2 exposure. Using proteomics, we identified 550 unique proteins; including 474 in H2O2-exposed PSCs (H-PSCs) samples and 515 in non-exposed PSCs (C-PSCs) samples. Larger amounts of antioxidant proteins, including GSTs and novel carbonyl detoxifying enzymes, such as aldo-keto reductase and carbonyl reductase, were detected after H2O2 exposure. Increased concentrations of caspase-3 and cathepsin-D proteases and components of the 26S proteasome were also detected in H-PSCs. Reduction of lamin-B and other caspase-substrate, such as filamin, in H-PSCs suggested that molecular events related to early apoptosis were also induced. We present data that describe proteins expressed in response to oxidative stress in a metazoan parasite, including novel antioxidant enzymes and targets with potential application to treatment and prevention of CHD.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31685918 PMCID: PMC6828748 DOI: 10.1038/s41598-019-52456-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1E. granulosus PSCs incubated with H2O2. PSCs were cultured with different H2O2 concentrations (0, 1.0, 2.5, and 5.0 mM) and incubation times (2 h and 4 h). The figure represents the results obtained from two biological replicates (PSCs from two different cysts). Scale bar: 40 μm.
Figure 2Overview of the proteins identified in the C-PSCs and H-PSCs samples. (a) The numbers of proteins exclusively detected in each sample or shared between them are indicated in the diagram. Only proteins identified by at least two peptides and present in the two biological replicates were considered for analysis. (b) Volcano plot of proteins shared between C-PSCs and H-PSCs, with significant differences between samples. Proteins with a p value < 0.05 (−log10 = 1.3) and a fold-change (FC) > 1.5 (log2 = 0.5) were considered differentially abundant between H-PSC and C-PSC by both statistical and FC parameters and are represented by black dots and identified by their numbering in Table S4. Proteins without significant differences in abundance between samples according to the criteria above are shown as grey dots.
Proteins up-regulated in C-PSCs samples.
| Protein name | Accession codea | Quantitative values (NSAF) | Fold change (FC)b | ||
|---|---|---|---|---|---|
| C-PSCs | H-PSCs | ||||
| Acidic leucine rich nuclear phosphoprotein | EgrG_001104800 | 0.013 | 0.0488735 | 0.0167205 | 2.92 |
| Aldehyde dehydrogenase mitochondrial | EgrG_000389100 | 0.0001 | 0.062014 | 0.00645025 | 9.61 |
| Aminopeptidase | EgrG_001105200 | 0.0063 | 0.0253525 | 0.0067329 | 3.76 |
| Aminotransferase class III (Ornithine aminotransferase) | EgrG_001032200 | 0.01 | 0.097817 | 0.039335 | 2.48 |
| Asparaginyl tRNA synthetase cytoplasmic | EgrG_000348600 | 0.0024 | 0.097845 | 0.040421 | 2.42 |
| Aspartate aminotransferase | EGR_07719 | 0.0039 | 0.087438 | 0.0411095 | 2.12 |
| Betaine aldehyde dehydrogenase | EgrG_000904200 | 0.021 | 0.0259865 | 0.00833905 | 3.11 |
| Calcium-transporting ATPase | EGR_06085 | 0.0024 | 0.00911835 | 0.002885 | 3.16 |
| Calnexin | EGR_06707 | 0.031 | 0.0343755 | 0.00996025 | 3.45 |
| Cysteine and glycine rich protein 1 (Cysteine and glycine-rich protein) | EgrG_000893500 | 0.043 | 0.107258 | 0.0514965 | 2.08 |
| Cytoplasmic dynein 1 heavy chain | EGR_01376 | 0.011 | 0.0028364 | 0.000907625 | 3.12 |
| Dehydrogenase/reductase SDR family member | EGR_07430 | 0.00069 | 0.029967 | 0.0089241 | 3.35 |
| Dipeptidyl peptidase 3 (Dipeptidyl peptidase III) | EgrG_001028100 | 0.017 | 0.024112 | 0.0086011 | 2.80 |
| Endophilin B2 | EgrG_000060900 | 0.022 | 0.129905 | 0.0405845 | 3.20 |
| Glutathione S-transferase | EGR_07276 | 0.041 | 0.24975 | 0.153215 | 1.63 |
| Gynecophoral canal protein | EgrG_000824400 | 0.038 | 0.0236955 | 0.00926185 | 2.55 |
| Lamin-B2 | EGR_02565 | 0.0082 | 0.021778 | 0.0016971 | 12.83 |
| LIM zinc bindingdomain containing protein | EgrG_000539800 | 0.0038 | 0.0350835 | 0.019154 | 1.83 |
| Major vault protein | EgrG_000142500 | 0.015 | 0.379795 | 0.12536 | 3.02 |
| Mitochondrial dicarboxylate carrier | EgrG_000595000 | 0.013 | 0.0510985 | 0.021425 | 2.38 |
| Purine nucleoside phosphorylase (PNP) | EgrG_000622900 | 0.039 | 0.098687 | 0.0269765 | 3.65 |
| Pyrroline 5 carboxylate reductase | EgrG_000233100 | 0.0011 | 0.0099199 | 0.00361065 | 2.74 |
| Serine protease inhibitor | EgrG_001193100 | 0.015 | 0.060694 | 0.0244525 | 2.48 |
| Seryl tRNA Synthetase | EgrG_001197300 | 0.01 | 0.0484465 | 0.0062857 | 7.70 |
| Tegumental protein | EGR_08411 | 0.047 | 0.036927 | 0.01000965 | 3.69 |
| Telomerase protein component 1 | EgrG_001036600 | 0.041 | 0.022413 | 0.0065969 | 3.39 |
| Transaldolase | EGR_10111 | 0.009 | 0.0749545 | 0.0206575 | 3.62 |
| Troponin I 4 | EGR_06361 | 0.014 | 0.0929875 | 0.060291 | 1.54 |
| Tubulin polymerization promoting protein family | EgrG_000096900 | 0.016 | 0.073331 | 0.01876 | 3.90 |
aProtein accession codes were retrieved from E. granulosus genome annotation available on WormBase ParaSite (http://www.parasite.wormbase.org/).
bFold changes were based on NSAF values from ‘C-PSCs’ divided by those of ‘H-PSCs’.
Proteins up-regulated in H-PSCs samples.
| Protein name | Accession codea | Quantitative values (NSAF) | Fold change (FC)b | ||
|---|---|---|---|---|---|
| C-PSCs | H-PSCs | ||||
| 26S proteasome non-ATPase regulatory subunit | EgrG_000736900 | 0.048 | 0.00686595 | 0.0148795 | 2.17 |
| 40S ribosomal protein S13 | EgrG_000856900 | 0.036 | 0.019052 | 0.058467 | 3.06 |
| 6 phosphogluconolactonase | EgrG_000445200 | 0.025 | 0.0117905 | 0.029843 | 2.53 |
| Adenosylhomocysteinase | EGR_05478 | 0.026 | 0.0077762 | 0.0193915 | 2.49 |
| Cathepsin d lysosomal aspartyl protease | EgrG_000970500 | 0.016 | 0.0158975 | 0.075669 | 4.76 |
| Collagen alpha-1(IV) chain | EGR_08512 | 0.0035 | 0.0142325 | 0.021473 | 1.50 |
| Collagen alpha-1(XXIV) chain | EGR_03871 | 0.0018 | 0.0014417 | 0.0090935 | 6.30 |
| Elongation factor 1-alpha | EgrG_000982200 | 0.049 | 0.091483 | 0.15607 | 1.70 |
| Estradiol 17 beta-dehydrogenase | EGR_09847 | 0.0021 | 0.0098417 | 0.18411 | 18.70 |
| Fatty acid amide hydrolase 1 | EgrG_000743700 | 0.034 | 0.014514 | 0.03086 | 2.12 |
| GDP L fucose synthase | EgrG_000476900 | 0.0042 | 0.0196555 | 0.0427775 | 2.17 |
| Glycerol-3-phosphate dehydrogenase NAD | EgrG_000686100 | 0.00019 | 0.010596 | 0.027413 | 2.58 |
| Glycerol-3-phosphate dehydrogenase NAD(+) | EGR_09089 | 0.003 | 0.00262725 | 0.044269 | 16.84 |
| Glycogen debranching enzyme | EgrG_000644500 | 0.039 | 0.00428925 | 0.018231 | 4.25 |
| Heat shock protein 105 | EgrG_000917000 | 0.02 | 0.018896 | 0.0419425 | 2.21 |
| Histone | EgrG_002016600 | 0.043 | 0.0710695 | 0.18414 | 2.59 |
| Large subunit ribosomal protein 23 | EgrG_000954600 | 0.0071 | 0.0174355 | 0.038076 | 2.18 |
| Long chain fatty acid coenzyme A ligase 4 | EgrG_000376500 | 0.0077 | 0.0084074 | 0.0242155 | 2.88 |
| Nucleoside diphosphate kinase | EGR_05582 | 0.048 | 0.074672 | 0.152835 | 2.04 |
| Protein disulfide-isomerase | EGR_08944 | 0.039 | 0.031717 | 0.051831 | 1.63 |
| Splicing factor U2AF subunit (U2 small nuclear RNA auxiliary factor 2) | EgrG_000625400 | 0.014 | 0.0037978 | 0.00622035 | 1.63 |
| Succinyl-CoA synthetase subunit alpha | EGR_08424 | 0.03 | 0.015809 | 0.047168 | 2.98 |
| Zinc phosphodiesterase elac protein 1 | EgrG_000149350 | 0.0089 | 0.00665745 | 0.0261045 | 3.92 |
aProtein accession codes were retrieved from E. granulosus genome annotation available on WormBase ParaSite (http://www.parasite.wormbase.org/).
bFold changes were based on NSAF values from ‘H-PSC’ divided by those of ‘C-PSC’.
Figure 3In toto immunolocalization of GST during PSCs oxidative stress response. PSCs were incubated in RPMI-10% FBS (C-PSCs) (A to H) or RPMI-10% FBS supplemented with 2.5 mM H2O2 (H-PSCs) (I to L). After PFA fixing, PSCs were incubated with anti-GST antibody (G and K) (GST) (green) and counterstained with DAPI-phalloidin (DAPI/PHAL) (see Materials and Methods section). Negative control consisted of omission of primary antibody (C). A, E, and I show the bright field and merge of the three channels in D, H and L. Scale bar = 20 μm. P: parenchyma: S: sucker: Tg: tegument.
Figure 4Molecular pathway linked to oxidative stress response in E. granulosus PSCs. Exposure to H2O2 and other ROS/RNS can cause macromolecule oxidation at the tegumental surface of PSC leading to reactive carbonyls production. Expression of GST at the parasite surface can contribute with the detoxification of some toxic aldehydes (i.e., trans-2-nonenal). Other carbonyl detoxifying enzymes (AKRs, CBRs, and GSTs) are up-regulated to prevent lipid, protein, and DNA damage. Protein modification can cause protein aggregation that can be inhibited by Hsp70 chaperone or degraded by targeting ubiquitinated proteins to 26S proteasome (ADRM1, PSMD2, UCH-L3, and 26S ATP). Damaged mitochondrial membrane and nuclear/mitochondrial DNA could be responsible for initial events of apoptosis, inducing caspase-3 activation and cleavage of protein substrates such as filamins and lamins. ER stress induced by oxidative stress can also be associated with PSC apoptosis. Glycerol production can protect cells from hyperosmotic and oxidative stress. EV: extracellular vesicle, Cytc: cytochrome c, CatD: cathepsin D, Cnx: calnexin, PDI: protein disulfide isomerase.
Protein targets for drug repositioning. E. granulosus H-PSCs up-regulated proteins for which there are available inhibitory drugs previously used for the treatment of different infections/diseases.
| Target | Drug | Mechanism of action | Disease or pathogen treatable by the drug | Ref |
|---|---|---|---|---|
| Glycerol-3-phosphate dehydrogenase | Anacardic acids | Non-competitive enzyme inhibition | Tumors and Bacterial pathogens |
[ |
| Carbonyl reductase | Biphenyl compounds | Enzyme inhibition | Breast cancer |
[ |
| Cathepsin D | Amprenavira, Indinavira, Lopinavira, Nelfinavira, Ritonavira, Saquinavira | Enzyme inhibition | Human Immunodeficiency Virus Trypanosomatids: |
[ |
| Estradiol 17-beta dehydrogenase | Steroidal STX1040 and non-steroidal PBRM | Enzyme inhibition | Breast cancer |
[ |
| Glutathione-S-transferase | Ethacrynic acid analoguesa | Enzyme inhibition | Cancers |
[ |
| Glutathione analogues: ezatiostat (TLK199) | Myelodysplastic syndrome |
[ | ||
| Proteasome subunits | Bortezomiba | Inhibition of p53 degradation? | Multiple myeloma |
[ |
| Epoxomicin | Proteasome inhibition |
|
[ | |
| Carmaphycin B analogs | Proteasome inhibition |
|
[ |
aFDA-approved drugs.